Free Trial

ADC Therapeutics (ADCT) Insider Trading & Ownership

ADC Therapeutics logo
$2.39 -0.26 (-9.81%)
(As of 11/15/2024 ET)

ADC Therapeutics (NYSE:ADCT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.10%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$1.12 M
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$153,410.43
Get ADCT Insider Trade Alerts

Want to know when executives and insiders are buying or selling ADC Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ADCT Insider Buying and Selling by Quarter

ADC Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/1/2024Redmile Group, LlcMajor ShareholderBuy400,000$2.81$1,124,000.00  
6/17/2024Robert AzelbyDirectorSell6,995$2.89$20,215.55  
5/7/2024Ameet MallikCEOSell29,731$4.48$133,194.88  
(Data available from 1/1/2013 forward)

ADCT Insider Trading Activity - Frequently Asked Questions

The list of insiders at ADC Therapeutics includes Ameet Mallik, Redmile Group, Llc, and Robert Azelby. Learn more on insiders at ADCT.

4.10% of ADC Therapeutics stock is owned by insiders. Learn more on ADCT's insider holdings.

The following insider purchased ADCT shares in the last 24 months: Redmile Group, Llc ($1,124,000.00).

Insiders have purchased a total of 400,000 ADCT shares in the last 24 months for a total of $1,124,000.00 bought.

The following insiders have sold ADCT shares in the last 24 months: Ameet Mallik ($133,194.88), and Robert Azelby ($20,215.55).

Insiders have sold a total of 36,726 ADC Therapeutics shares in the last 24 months for a total of $153,410.43 sold.

ADC Therapeutics Key Executives

  • Dr. Ameet Mallik M.B.A. (Age 51)
    M.S., CEO & Director
    Compensation: $1.84M
  • Mr. Jose I. Carmona M.B.A. (Age 52)
    Chief Financial Officer
    Compensation: $884.86k
  • Dr. Mohamed Zaki M.D. (Age 59)
    Ph.D., Chief Medical Officer
    Compensation: $2.41M
  • Ms. Lisa Michelle Kallebo
    Corporate Controller & Chief Accounting Officer
  • Dr. Michael Mulkerrin Ph.D. (Age 69)
    Chief Technical Operations Officer
  • Dr. Patrick van Berkel Ph.D. (Age 56)
    Chief Scientific Officer
  • Amanda Hamilton
    Investor Relations Officer
  • Mr. Peter J. Graham Esq. (Age 57)
    Chief Legal Officer
  • Ms. Eugenia Litz
    Vice President of Investor Relations & Corporate Communications
  • Ms. Kimberly Pope (Age 57)
    Senior VP & Chief People Officer


This page (NYSE:ADCT) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners